首页> 外文OA文献 >Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

【2h】

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

机译：勘误至：SABRTooth可行性试验方案：一项研究，用于研究在考虑的外周I期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术的比较的III期随机对照试验的可行性和可接受性手术切除并发症的风险较高

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
M. P. Snee; L. McParland; F. Collinson; C. M. Lowe; A. Striha; D. R. Baldwin; B. Naidu; D. Sebag-Montefiore; W. M. Gregory; J. Bestall; J. Hewison; S. Hinsley; K. N. Franks;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection [J] . M. P. Snee, L. McParland, F. Collinson, Pilot and Feasibility Studies . 2016,第1期

机译：SABRTooth可行性试验方案：一项研究，用于确定在III期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术比较的III期随机对照试验的可行性和可接受性手术切除引起并发症的风险更高
2. P1.05-029 SABRTOOTH-A Feasibility Study of SABR Compared to Surgery in Patients with Peripheral Stage I NSCLC Considered to Be at Higher Risk from Surgery [J] . Kevin Franks, Michael Snee, Babu Naidu, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P1.05-029 SABRTOOTH-A SABR的可行性与外周阶段患者手术相比，I NSCLC被认为是手术的较高风险
3. P1.05-029 SABRTOOTH-A Feasibility Study of SABR Compared to Surgery in Patients with Peripheral Stage I NSCLC Considered to Be at Higher Risk from Surgery [J] . Kevin Franks, Michael Snee, Babu Naidu, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P1.05-029 SABRTOOTH-A SABR的可行性与外周阶段患者手术相比，I NSCLC被认为是手术的较高风险
4. Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection [O] . M. P. Snee, L. McParland, F. Collinson, 2016

机译：勘误至：SABRTooth可行性试验方案：一项研究用于研究在考虑的外周I期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术的比较的III期随机对照试验的可行性和可接受性手术切除并发症的风险较高
5. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection [O] . 2016

机译：SABRTooth可行性试验方案：一项研究，用于确定在III期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术比较的III期随机对照试验的可行性和可接受性手术切除并发症的风险更高
6. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

著录项

相似文献

相关主题

期刊订阅